DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,378,000 | +2.8% | 167,538 | +90.4% | 0.02% | +5.9% |
| Q2 2021 | $3,285,000 | -45.5% | 88,011 | -62.7% | 0.02% | -50.0% |
| Q1 2021 | $6,032,000 | -8.7% | 235,884 | -21.3% | 0.03% | -12.8% |
| Q4 2020 | $6,607,000 | +23.3% | 299,901 | +0.6% | 0.04% | +8.3% |
| Q3 2020 | $5,360,000 | -22.5% | 297,971 | +9.4% | 0.04% | -26.5% |
| Q2 2020 | $6,919,000 | +27.6% | 272,386 | -7.7% | 0.05% | 0.0% |
| Q1 2020 | $5,422,000 | +32.4% | 295,175 | +58.8% | 0.05% | +75.0% |
| Q4 2019 | $4,094,000 | +931.2% | 185,850 | +169.4% | 0.03% | +1300.0% |
| Q3 2017 | $397,000 | +58.2% | 68,975 | -13.0% | 0.00% | 0.0% |
| Q2 2017 | $251,000 | +19.5% | 79,275 | +28.5% | 0.00% | +100.0% |
| Q1 2017 | $210,000 | +57.9% | 61,700 | +33.8% | 0.00% | 0.0% |
| Q4 2016 | $133,000 | -12.5% | 46,100 | +78.0% | 0.00% | 0.0% |
| Q3 2016 | $152,000 | +149.2% | 25,900 | +27.0% | 0.00% | – |
| Q2 2016 | $61,000 | -59.6% | 20,400 | -27.4% | 0.00% | -100.0% |
| Q1 2016 | $151,000 | -55.3% | 28,100 | -1.4% | 0.00% | -66.7% |
| Q4 2015 | $338,000 | +79.8% | 28,500 | +24.5% | 0.00% | +50.0% |
| Q3 2015 | $188,000 | -17.9% | 22,900 | +39.6% | 0.00% | 0.0% |
| Q2 2015 | $229,000 | -41.9% | 16,400 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $394,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|